Last night (November 8th) the U.S. House of Representatives passed a bill aiming to linkurl:increase;http://www.the-scientist.com/news/display/45169/ NIH funding from $28.6 billion linkurl:this year;http://www.the-scientist.com/news/display/49077/ to $30 billion next year. Jon Retzlaff, spokesperson for the Federation of American Societies for Experimental Biology (FASEB), said he expects President Bush to linkurl:veto;http://www.the-scientist.com/news/display/53366/ the bill when it lands on his desk tomorrow or early next week, because it oversteps the administration's suggested funding levels. The bill passed by a vote of 274-141, just three votes shy of obtaining an automatic veto override. The bill linkurl:(H.R.3043);http://thomas.loc.gov/cgi-bin/bdquery/z?d110:HR03043:@@@R has been knocking around on Capitol Hill since July 13, when it was linkurl:introduced;http://www.the-scientist.com/news/display/53288/ in the House. In the intervening months, legislators have added amendments to and trimmed funding from the original bill, also piggybacking and uncoupling it from other bills in efforts to subvert the imminent veto. It cleared the Senate on Wednesday. If the president does veto the bill,...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
